RVNC Investors Have Opportunity to Lead Revance Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm – Revance Therapeutics (NASDAQ:RVNC)
LOS ANGELES, Jan. 10, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Revance ...
Read more